Injective CEO discusses regulatory wins and upcoming launches on Talking Tokens podcast

Eric Chen: Eric Chen is the co-founder and CEO of Injective, where he directs strategy for onchain finance infrastructure and institutional adoption. He has extensive experience in crypto protocol development and frequently discusses the intersection of AI and blockchain innovation. In the reported podcast appearance, Chen details Injective's regulatory progress and vision for tokenizing assets beyond basic representation. Injective: Injective is a blockchain protocol specializing in onchain finance with a focus on decentralized perpetual markets and real-world asset tokenization. It enables trading and settlement across equities, FX, commodities, and pre-IPO assets while supporting enterprise integrations for supply chain and real estate applications. In this news, the protocol's CEO highlights recent U.S. and international regulatory approvals for $INJ along with major upcoming product launches. RWA Perps: Perpetual markets for real-world assets across multiple classes are emerging as a central growth area for onchain finance platforms like Injective. Regulation: Injective recently secured SEC transfer agent registration, which facilitates onchain asset tokenization and compliant capital raising. Enterprise Adoption: Companies including POSCO International, LG CNS, and Pineapple Financial are actively building supply chain and real-estate tokenization solutions on Injective.